Infection Surveillance Solutions Market

Executive Summary

Infection Surveillance Solutions Market was valued at US $588.19 million in 2021 and is projected to grow at 15.79% CAGR over the forecast period to reach US $1,417.21 million by 2027. Infection Surveillance Solutions Market represented US $149.45 million opportunity over 2019-2021 and estimated to create US $829.03 million opportunity in 2027 over 2021.

Infection Surveillance Solutions from Consainsights analyses the Infection Surveillance Solutions Market in the Life Sciences industry over the forecast period to 2027.

Infection Surveillance Solutions research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Infection Surveillance Solutions segmentation includes Product, End User and Geography.

Based on the Product, the Infection Surveillance Solutions analysis covers Software, Services.

In Product segment, Software segment has highest cagr growth of 13.91%.

Based on the End User, the Infection Surveillance Solutions analysis covers Hospitals, Long-term Care Facilities, Other End Users.

In End User segment, Hospitals segment has highest cagr growth of 13.91%.

Based on the region, the Infection Surveillance Solutions analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Becton, Dikinson And Company, Premier Inc., Wolters Kluwer N.V., Baxter International Inc., Gojo Industries, Inc., Rl Solutions, Truven Health Analytics (An Ibm Company), Deb Group Ltd., Hygreen, Inc., Atlas Medical Software and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, Software segment has the highest revenue of US $358.99 million and is expected to grow at CAGR of 13.91% by 2027 Software segment has highest cagr growth of 13.91%.

Software

Software segment was valued at US $267.78 million in 2019 and is projected to grow at 13.91% CAGR over the forecast period to reach US $864.98 million by 2027. Software segment represented US $91.21 million opportunity over 2019-2021 and estimated to create US $505.99 million opportunity in 2027 over 2021.

Services

Services segment was valued at US $170.96 million in 2019 and is projected to grow at 13.91% CAGR over the forecast period to reach US $552.23 million by 2027. Services segment represented US $58.23 million opportunity over 2019-2021 and estimated to create US $323.04 million opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $352.07 million and is expected to grow at CAGR of 13.91% by 2027 Hospitals segment has highest cagr growth of 13.91%.

Hospitals

Hospitals segment was valued at US $262.62 million in 2019 and is projected to grow at 13.91% CAGR over the forecast period to reach US $848.29 million by 2027. Hospitals segment represented US $89.45 million opportunity over 2019-2021 and estimated to create US $496.23 million opportunity in 2027 over 2021.

Long-term Care Facilities

Long-term Care Facilities segment was valued at US $175.12 million in 2019 and is projected to grow at 13.91% CAGR over the forecast period to reach US $565.65 million by 2027. Long-term Care Facilities segment represented US $59.65 million opportunity over 2019-2021 and estimated to create US $330.89 million opportunity in 2027 over 2021.

Other End Users

Other End Users segment was valued at US $1.01 million in 2019 and is projected to grow at 13.91% CAGR over the forecast period to reach US $3.27 million by 2027. Other End Users segment represented US $0.34 million opportunity over 2019-2021 and estimated to create US $1.91 million opportunity in 2027 over 2021.